ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 037,66
-0,34%
Dow Jones
38 386,09
0,38%
DAX
18 028,60
-0,57%
Brent Oil
87,445
0,18%
Bitcoin
61 934,33
-2,98%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eagle Pharmaceuticals Inc (EGRX)

  7. Eagle Pharmaceuticals Inc (EGRX) Actualités

EGRX Eagle Pharmaceuticals Inc

4,05
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:01:51
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Eagle Pharmaceuticals Inc EGRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 4,05 10:01:51
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,05
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202422:49EDGAR2Form 8-K - Current report
01/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202413:35EDGAR2Form 8-K - Current report
01/3/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:09EDGAR2Form 8-K - Current report
14/2/202423:09EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13/2/202421:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:50EDGAR2Form 8-K - Current report
09/2/202411:45PRNUSEagle Pharmaceuticals, Inc. Securities Fraud Class Action..
07/2/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
18/1/202412:56EDGAR2Form 8-K - Current report
18/1/202412:50GLOBEEagle Pharmaceuticals Provides Update on Bendamustine..
16/1/202413:00EDGAR2Form 8-K - Current report
12/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
09/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
23/12/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202323:15EDGAR2Form 8-K/A - Current report: [Amend]
20/12/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
15/12/202323:11EDGAR2Form 8-K - Current report
06/12/202322:26EDGAR2Form 8-K - Current report
06/12/202322:05GLOBEEagle Pharmaceuticals to Present Abstract on Post-hoc..
29/11/202313:39EDGAR2Form 8-K - Current report
29/11/202313:36EDGAR2Form 8-K - Current report
09/11/202323:23EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202313:57EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEEagle Delays Third Quarter 2023 Results and Conference Call
08/11/202314:30GLOBEEagle Pharmaceuticals to Host Third Quarter 2023 Financial..
03/11/202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202321:53EDGAR2Form 144 - Report of proposed sale of securities
01/11/202322:02EDGAR2Form 144 - Report of proposed sale of securities
31/10/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202314:49EDGAR2Form 8-K - Current report
24/10/202314:40GLOBEEagle Pharmaceuticals Granted Patent for PEMFEXY®
23/10/202313:10EDGAR2Form 8-K - Current report
23/10/202312:50GLOBEEagle Pharmaceuticals Granted Unique J-Code and Pass-Through..
04/10/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202312:50GLOBEEagle Pharmaceuticals Awarded First Prize for Poster to Be..
03/10/202322:48EDGAR2Form 144 - Report of proposed sale of securities
02/10/202322:51EDGAR2Form 144 - Report of proposed sale of securities
27/9/202313:00EDGAR2Form 8-K - Current report
19/9/202322:05GLOBEEagle Pharmaceuticals to Present at the Cantor Global..
11/9/202312:50GLOBEEagle Pharmaceuticals to Present CAL02 Trial in Progress at..

Dernières Valeurs Consultées

NASDAQ
EGRX
Eagle Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés